STAT1 (signal transducer and activator of transcription 1)
|
Gene
|
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
6772 |
Gene nameGene Name - the full gene name approved by the HGNC.
|
Signal transducer and activator of transcription 1 |
Gene symbolGene Symbol - the official gene symbol approved by the HGNC, which is a short abbreviated form of the gene name.
|
STAT1 |
SynonymsGene synonyms aliases
|
CANDF7, IMD31A, IMD31B, IMD31C, ISGF-3, STAT91 |
ChromosomeChromosome number
|
2 |
Chromosome locationChromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
2q32.2 |
SummarySummary of gene provided in NCBI Entrez Gene.
|
The protein encoded by this gene is a member of the STAT protein family. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. The protein encoded by this gene can be activated by various ligands including interferon-alpha, interferon-gamma, EGF, PDGF and IL6. This protein mediates the expression of a variety of genes, which is thought to be important for cell viability in response to different cell stimuli and pathogens. The protein plays an important role in immune responses to viral, fungal and mycobacterial pathogens. Mutations in this gene are associated with Immunodeficiency 31B, 31A, and 31C. [provided by RefSeq, Jun 2020] |
SNPsSNP information provided by dbSNP.
|
SNP ID |
Visualize variation |
Clinical significance |
Consequence |
rs41473544 |
C>T |
Likely-benign, pathogenic, uncertain-significance |
Coding sequence variant, missense variant, non coding transcript variant |
rs56228116 |
C>T |
Likely-benign, conflicting-interpretations-of-pathogenicity |
Intron variant |
rs137852677 |
A>G |
Pathogenic |
Non coding transcript variant, coding sequence variant, missense variant |
rs137852678 |
A>G |
Pathogenic |
Non coding transcript variant, coding sequence variant, missense variant |
rs137852679 |
C>A,T |
Pathogenic |
Non coding transcript variant, synonymous variant, coding sequence variant, missense variant |
rs137852680 |
C>G |
Pathogenic |
Non coding transcript variant, coding sequence variant, missense variant |
rs387906758 |
G>A,C |
Likely-pathogenic, pathogenic |
Missense variant, coding sequence variant, non coding transcript variant |
rs387906759 |
G>A |
Pathogenic |
Missense variant, coding sequence variant, non coding transcript variant |
rs387906760 |
C>T |
Pathogenic |
Missense variant, coding sequence variant, non coding transcript variant |
rs387906761 |
T>A |
Pathogenic |
Missense variant, coding sequence variant, non coding transcript variant |
rs387906762 |
T>C |
Pathogenic |
Missense variant, coding sequence variant, non coding transcript variant |
rs387906763 |
A>G |
Likely-pathogenic, pathogenic |
Missense variant, coding sequence variant, non coding transcript variant |
rs387906764 |
T>C |
Pathogenic |
Missense variant, coding sequence variant, non coding transcript variant |
rs387906765 |
T>C |
Pathogenic |
Missense variant, coding sequence variant, non coding transcript variant |
rs387906766 |
A>T |
Pathogenic |
Missense variant, coding sequence variant, non coding transcript variant |
rs387906767 |
C>G |
Pathogenic |
Missense variant, coding sequence variant, non coding transcript variant |
rs387906768 |
T>G |
Pathogenic |
Missense variant, coding sequence variant, non coding transcript variant |
rs587776713 |
TC>- |
Pathogenic |
Non coding transcript variant, coding sequence variant, frameshift variant |
rs587776714 |
->T |
Pathogenic |
Non coding transcript variant, coding sequence variant, frameshift variant |
rs587776870 |
C>A |
Pathogenic |
Missense variant, non coding transcript variant, coding sequence variant |
rs587777628 |
G>T |
Pathogenic |
Missense variant, non coding transcript variant, coding sequence variant |
rs587777629 |
T>C |
Pathogenic |
Missense variant, non coding transcript variant, coding sequence variant |
rs587777630 |
G>A |
Pathogenic |
Missense variant, non coding transcript variant, coding sequence variant |
rs587777704 |
T>C |
Pathogenic |
Missense variant, non coding transcript variant, coding sequence variant |
rs587777705 |
T>C |
Pathogenic |
Missense variant, non coding transcript variant, coding sequence variant |
rs755837357 |
TTCT>- |
Likely-pathogenic |
Frameshift variant, coding sequence variant, non coding transcript variant |
rs778254943 |
G>A |
Likely-pathogenic |
Missense variant, non coding transcript variant, coding sequence variant |
rs796065052 |
C>T |
Pathogenic |
Coding sequence variant, non coding transcript variant, missense variant |
rs863223398 |
T>C |
Pathogenic |
Coding sequence variant, non coding transcript variant, missense variant |
rs886043118 |
T>- |
Pathogenic |
Coding sequence variant, frameshift variant, non coding transcript variant |
rs1064794955 |
C>A |
Likely-pathogenic |
Missense variant, coding sequence variant, non coding transcript variant |
rs1085307649 |
G>T |
Likely-pathogenic |
Missense variant, coding sequence variant, non coding transcript variant |
rs1341038926 |
->C |
Likely-pathogenic |
Non coding transcript variant, coding sequence variant, frameshift variant |
rs1553494436 |
A>C |
Likely-pathogenic |
Non coding transcript variant, coding sequence variant, missense variant |
rs1553495184 |
T>C |
Pathogenic |
Non coding transcript variant, coding sequence variant, missense variant |
rs1553496850 |
T>C |
Likely-pathogenic |
Non coding transcript variant, coding sequence variant, missense variant |
rs1553497886 |
T>A |
Likely-pathogenic |
Non coding transcript variant, coding sequence variant, missense variant |
rs1559011859 |
T>G |
Likely-pathogenic |
Non coding transcript variant, coding sequence variant, missense variant |
rs1559019204 |
C>T |
Pathogenic |
Non coding transcript variant, coding sequence variant, missense variant |
rs1574636674 |
G>A |
Likely-pathogenic |
Non coding transcript variant, genic downstream transcript variant, coding sequence variant, missense variant |
rs1574640523 |
C>A |
Likely-pathogenic |
Non coding transcript variant, stop gained, coding sequence variant |
rs1574648928 |
C>G |
Pathogenic |
Non coding transcript variant, coding sequence variant, missense variant |
rs1574653439 |
A>G |
Likely-pathogenic |
Non coding transcript variant, coding sequence variant, missense variant |
rs1574657735 |
A>C |
Likely-pathogenic |
Non coding transcript variant, coding sequence variant, missense variant |
rs1574657750 |
C>T |
Likely-pathogenic |
Non coding transcript variant, coding sequence variant, missense variant |
rs1574657762 |
A>C |
Likely-pathogenic |
Non coding transcript variant, coding sequence variant, missense variant |
rs1574672718 |
C>G |
Likely-pathogenic |
Non coding transcript variant, coding sequence variant, missense variant |
|
miRNAmiRNA information provided by mirtarbase database.
|
miRTarBase ID |
miRNA |
Experiments |
Reference |
MIRT000626 |
hsa-miR-145-5p |
qRT-PCR, Luciferase reporter assay, Western blot, Microarray |
20098684 |
MIRT021229 |
hsa-miR-146a-5p |
Microarray |
20110513 |
MIRT021229 |
hsa-miR-146a-5p |
Luciferase reporter assay, qRT-PCR, Western blot |
23890093 |
MIRT021229 |
hsa-miR-146a-5p |
Luciferase reporter assay |
23698745 |
MIRT021229 |
hsa-miR-146a-5p |
qRT-PCR, Western blot |
25889446 |
MIRT021229 |
hsa-miR-146a-5p |
qRT-PCR |
28077577 |
MIRT025278 |
hsa-miR-34a-5p |
Proteomics |
21566225 |
MIRT040456 |
hsa-miR-615-3p |
CLASH |
23622248 |
MIRT640316 |
hsa-miR-653-5p |
HITS-CLIP |
23824327 |
MIRT640317 |
hsa-miR-203b-3p |
HITS-CLIP |
23824327 |
MIRT640318 |
hsa-miR-7158-3p |
HITS-CLIP |
23824327 |
MIRT640319 |
hsa-miR-4693-5p |
HITS-CLIP |
23824327 |
MIRT640320 |
hsa-miR-5009-3p |
HITS-CLIP |
23824327 |
MIRT640321 |
hsa-miR-501-5p |
HITS-CLIP |
23824327 |
MIRT640322 |
hsa-miR-1183 |
HITS-CLIP |
23824327 |
MIRT640323 |
hsa-miR-500a-5p |
HITS-CLIP |
23824327 |
MIRT640324 |
hsa-miR-605-5p |
HITS-CLIP |
23824327 |
MIRT731704 |
hsa-miR-140-5p |
Luciferase reporter assay, Western blot |
26780721 |
MIRT733223 |
hsa-miR-150-5p |
Luciferase reporter assay, qRT-PCR, Western blot |
26025667 |
MIRT733224 |
hsa-miR-223-3p |
Luciferase reporter assay, qRT-PCR, Western blot |
26025667 |
MIRT733720 |
hsa-miR-203a-3p |
Immunoblot, Luciferase reporter assay, Microarray, qRT-PCR |
27705947 |
MIRT734262 |
hsa-miR-450a-5p |
Luciferase reporter assay, Microarray, qRT-PCR |
28407302 |
MIRT734272 |
hsa-miR-155-5p |
Luciferase reporter assay, Western blot |
28418858 |
|
Transcription factors
|
|
Gene ontology (GO)Gene ontology information of associated ontologies with gene provided by GO database.
|
GO ID |
Ontology |
Definition |
Evidence |
Reference |
GO:0000122 |
Process |
Negative regulation of transcription by RNA polymerase II |
ISS |
|
GO:0000785 |
Component |
Chromatin |
IDA |
18035482 |
GO:0000785 |
Component |
Chromatin |
ISA |
|
GO:0000978 |
Function |
RNA polymerase II cis-regulatory region sequence-specific DNA binding |
IBA |
21873635 |
GO:0000978 |
Function |
RNA polymerase II cis-regulatory region sequence-specific DNA binding |
IDA |
18035482, 21268089 |
GO:0000979 |
Function |
RNA polymerase II core promoter sequence-specific DNA binding |
IDA |
23386060, 28753426 |
GO:0000981 |
Function |
DNA-binding transcription factor activity, RNA polymerase II-specific |
IBA |
21873635 |
GO:0000981 |
Function |
DNA-binding transcription factor activity, RNA polymerase II-specific |
IDA |
21268089 |
GO:0000981 |
Function |
DNA-binding transcription factor activity, RNA polymerase II-specific |
ISA |
|
GO:0001937 |
Process |
Negative regulation of endothelial cell proliferation |
IMP |
16585190 |
GO:0002053 |
Process |
Positive regulation of mesenchymal cell proliferation |
ISS |
|
GO:0002230 |
Process |
Positive regulation of defense response to virus by host |
IGI |
26479788 |
GO:0002230 |
Process |
Positive regulation of defense response to virus by host |
IMP |
26479788 |
GO:0003340 |
Process |
Negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis |
ISS |
|
GO:0003690 |
Function |
Double-stranded DNA binding |
IDA |
9630226 |
GO:0003700 |
Function |
DNA-binding transcription factor activity |
IDA |
10973496, 23386060 |
GO:0005164 |
Function |
Tumor necrosis factor receptor binding |
IPI |
10848577 |
GO:0005515 |
Function |
Protein binding |
IPI |
8156998, 8605877, 8662591, 9121453, 9881977, 10848577, 11238845, 12070153, 12788789, 12867595, 15780933, 15825084, 16189514, 16273093, 16306601, 16531398, 16940534, 17275127, 17596301, 17923090, 20195357, 21903422, 21988832, 24065129, 24360797, 24658140, 25241761, 25416956, 25609649 |
GO:0005634 |
Component |
Nucleus |
IDA |
10692450, 10973496, 15825084, 16306601, 21268089, 23386060, 28753426 |
GO:0005634 |
Component |
Nucleus |
IDA |
26479788 |
GO:0005654 |
Component |
Nucleoplasm |
IDA |
|
GO:0005654 |
Component |
Nucleoplasm |
TAS |
|
GO:0005730 |
Component |
Nucleolus |
IDA |
|
GO:0005737 |
Component |
Cytoplasm |
IDA |
10692450, 10973496, 15825084, 17275127, 23386060, 26479788, 27796300, 28753426 |
GO:0005829 |
Component |
Cytosol |
IDA |
|
GO:0005829 |
Component |
Cytosol |
TAS |
|
GO:0006952 |
Process |
Defense response |
IBA |
21873635 |
GO:0007221 |
Process |
Positive regulation of transcription of Notch receptor target |
TAS |
|
GO:0007259 |
Process |
Receptor signaling pathway via JAK-STAT |
IBA |
21873635 |
GO:0007259 |
Process |
Receptor signaling pathway via JAK-STAT |
IDA |
22002246 |
GO:0008015 |
Process |
Blood circulation |
ISS |
|
GO:0010742 |
Process |
Macrophage derived foam cell differentiation |
IDA |
26504087 |
GO:0016032 |
Process |
Viral process |
IEA |
|
GO:0016525 |
Process |
Negative regulation of angiogenesis |
IMP |
16585190 |
GO:0019221 |
Process |
Cytokine-mediated signaling pathway |
IBA |
21873635 |
GO:0019221 |
Process |
Cytokine-mediated signaling pathway |
TAS |
|
GO:0019899 |
Function |
Enzyme binding |
IPI |
22002246, 26479788 |
GO:0030424 |
Component |
Axon |
ISS |
|
GO:0030425 |
Component |
Dendrite |
ISS |
|
GO:0032727 |
Process |
Positive regulation of interferon-alpha production |
IDA |
28753426 |
GO:0032991 |
Component |
Protein-containing complex |
IDA |
26479788 |
GO:0033209 |
Process |
Tumor necrosis factor-mediated signaling pathway |
IDA |
10848577 |
GO:0034097 |
Process |
Response to cytokine |
ISS |
|
GO:0035035 |
Function |
Histone acetyltransferase binding |
IPI |
26479788 |
GO:0035257 |
Function |
Nuclear hormone receptor binding |
IPI |
26504087 |
GO:0035456 |
Process |
Response to interferon-beta |
IMP |
24882218 |
GO:0035458 |
Process |
Cellular response to interferon-beta |
IMP |
18035482 |
GO:0038113 |
Process |
Interleukin-9-mediated signaling pathway |
TAS |
|
GO:0038114 |
Process |
Interleukin-21-mediated signaling pathway |
TAS |
|
GO:0042127 |
Process |
Regulation of cell population proliferation |
IBA |
21873635 |
GO:0042393 |
Function |
Histone binding |
IPI |
26479788 |
GO:0042802 |
Function |
Identical protein binding |
IPI |
8605877, 9630226 |
GO:0042803 |
Function |
Protein homodimerization activity |
IDA |
9630226, 28753426 |
GO:0042981 |
Process |
Regulation of apoptotic process |
TAS |
12108949 |
GO:0043124 |
Process |
Negative regulation of I-kappaB kinase/NF-kappaB signaling |
IMP |
10848577 |
GO:0043434 |
Process |
Response to peptide hormone |
IBA |
21873635 |
GO:0043434 |
Process |
Response to peptide hormone |
ISS |
|
GO:0043542 |
Process |
Endothelial cell migration |
IMP |
16585190 |
GO:0044389 |
Function |
Ubiquitin-like protein ligase binding |
IPI |
26479788 |
GO:0045296 |
Function |
Cadherin binding |
HDA |
25468996 |
GO:0045648 |
Process |
Positive regulation of erythrocyte differentiation |
IMP |
28283061 |
GO:0045893 |
Process |
Positive regulation of transcription, DNA-templated |
IDA |
10973496 |
GO:0045893 |
Process |
Positive regulation of transcription, DNA-templated |
IGI |
26479788 |
GO:0045893 |
Process |
Positive regulation of transcription, DNA-templated |
IMP |
26479788 |
GO:0045944 |
Process |
Positive regulation of transcription by RNA polymerase II |
IMP |
18035482 |
GO:0046725 |
Process |
Negative regulation by virus of viral protein levels in host cell |
IMP |
15825084 |
GO:0048471 |
Component |
Perinuclear region of cytoplasm |
IDA |
17275127 |
GO:0048661 |
Process |
Positive regulation of smooth muscle cell proliferation |
ISS |
|
GO:0051591 |
Process |
Response to cAMP |
ISS |
|
GO:0051607 |
Process |
Defense response to virus |
IDA |
28753426 |
GO:0060333 |
Process |
Interferon-gamma-mediated signaling pathway |
IDA |
21268089 |
GO:0060333 |
Process |
Interferon-gamma-mediated signaling pathway |
IMP |
26479788 |
GO:0060333 |
Process |
Interferon-gamma-mediated signaling pathway |
ISS |
|
GO:0060333 |
Process |
Interferon-gamma-mediated signaling pathway |
TAS |
|
GO:0060334 |
Process |
Regulation of interferon-gamma-mediated signaling pathway |
TAS |
|
GO:0060337 |
Process |
Type I interferon signaling pathway |
IBA |
21873635 |
GO:0060337 |
Process |
Type I interferon signaling pathway |
IDA |
23386060 |
GO:0060337 |
Process |
Type I interferon signaling pathway |
ISS |
|
GO:0060337 |
Process |
Type I interferon signaling pathway |
TAS |
|
GO:0061326 |
Process |
Renal tubule development |
IMP |
20861313 |
GO:0070102 |
Process |
Interleukin-6-mediated signaling pathway |
TAS |
|
GO:0070106 |
Process |
Interleukin-27-mediated signaling pathway |
TAS |
|
GO:0070491 |
Function |
Repressing transcription factor binding |
IPI |
23386060 |
GO:0070757 |
Process |
Interleukin-35-mediated signaling pathway |
TAS |
|
GO:0071346 |
Process |
Cellular response to interferon-gamma |
IDA |
23386060 |
GO:0072136 |
Process |
Metanephric mesenchymal cell proliferation involved in metanephros development |
ISS |
|
GO:0072162 |
Process |
Metanephric mesenchymal cell differentiation |
ISS |
|
GO:0072308 |
Process |
Negative regulation of metanephric nephron tubule epithelial cell differentiation |
ISS |
|
GO:1990841 |
Function |
Promoter-specific chromatin binding |
IDA |
26479788 |
|
Other IDsOther ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|
Protein
|
UniProt ID |
P42224 |
Protein name |
Signal transducer and activator of transcription 1-alpha/beta (Transcription factor ISGF-3 components p91/p84) |
Protein function |
Signal transducer and transcription activator that mediates cellular responses to interferons (IFNs), cytokine KITLG/SCF and other cytokines and other growth factors. Following type I IFN (IFN-alpha and IFN-beta) binding to cell surface receptors, signaling via protein kinases leads to activation of Jak kinases (TYK2 and JAK1) and to tyrosine phosphorylation of STAT1 and STAT2. The phosphorylated STATs dimerize and associate with ISGF3G/IRF-9 to form a complex termed ISGF3 transcription factor, that enters the nucleus (PubMed:28753426). ISGF3 binds to the IFN stimulated response element (ISRE) to activate the transcription of IFN-stimulated genes (ISG), which drive the cell in an antiviral state. In response to type II IFN (IFN-gamma), STAT1 is tyrosine- and serine-phosphorylated (PubMed:26479788). It then forms a homodimer termed IFN-gamma-activated factor (GAF), migrates into the nucleus and binds to the IFN gamma activated sequence (GAS) to drive the expression of the target genes, inducing a cellular antiviral state. Becomes activated in response to KITLG/SCF and KIT signaling. May mediate cellular responses to activated FGFR1, FGFR2, FGFR3 and FGFR4. |
PDB |
1BF5
,
1YVL
,
2KA6
,
3WWT
|
Family and domains |
Pfam
Accession |
ID |
Position in sequence |
Description |
Type |
PF02865 |
STAT_int |
2 → 120 |
STAT protein, protein interaction domain |
Domain |
PF01017 |
STAT_alpha |
139 → 309 |
STAT protein, all-alpha domain |
Family |
PF02864 |
STAT_bind |
321 → 458 |
STAT protein, DNA binding domain |
Domain |
PF00017 |
SH2 |
573 → 657 |
SH2 domain |
Domain |
PF12162 |
STAT1_TAZ2bind |
715 → 739 |
STAT1 TAZ2 binding domain |
Motif |
|
Sequence |
|
Sequence length |
750 |
Interactions |
View interactions |
|
|